1-3 of 3
Darong Wu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Clinical Trial of Fully Human Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies

Brenda W Cooper, Molly Megan Gallogly, Leland Metheny, Rebecca B. Klisovic, Kirsten Marie Boughan, Jane Reese Koc, Darong Wu, Changchun Deng, Koen Van Besien, Rose Tupta, Dina Schneider, Lisa Ciarrone, Marcos de Lima, Paolo F. Caimi, Benjamin K. Tomlinson
Journal: Blood
Blood (2023) 142 (Supplement 1): 6872.
https://doi.org/10.1182/blood-2023-191153
Published: 2023
Journal Articles

Fully Human Tandem CD22-CD19 CAR-T Cells with Superior Sensitivity to Low Antigen Density Derived by Optimization of Co-Stimulation and CAR Architecture

Peirong Hu, PhD, Ying Xiong, PhD, Darong Wu, MS, Zhongyu Zhu, PhD, Boro Dropulic, PhDMBA, Dina Schneider, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-140836
Published: 2020
Journal Articles

A Fully-Human Armored BCMA CAR Boosts Function of CD4 + CAR-T Cells and Resists TGF-β Suppression in Pre-Clinical Models of Multiple Myeloma

Leah Alabanza, PhD, Bang Vu, PhD, Darong Wu, MS, Zhongyu Zhu, PhD, Boro Dropulic, PhDMBA, Dina Schneider, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-141062
Published: 2020